Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-03-07 @ 2:26 AM
Study NCT ID:
NCT03757234
Status:
COMPLETED
Last Update Posted:
2020-07-07
First Post:
2018-11-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis
Sponsor:
Paratek Pharmaceuticals Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PTK0796-AP-17202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None